Literature DB >> 3771769

Modified selective medium for isolation of Campylobacter spp. from feces: comparison with Preston medium, a blood-free medium, and a filtration system.

H Goossens, M De Boeck, H Coignau, L Vlaes, C Van den Borre, J P Butzler.   

Abstract

Our previously described (H. Goossens, M. De Boeck, and J. P. Butzler, Eur. J. Clin. Microbiol. 2:389-393, 1983) selective medium, consisting of cefoperazone (15 mg/liter), rifampin (10 mg/liter), colistin (10,000 IU/liter), and amphotericin B (2 mg/liter) (medium M1), for the isolation of Campylobacter jejuni and Campylobacter coli from stool specimens was modified as follows: cefoperazone (30 mg/liter), rifampin (10 mg/liter), and amphotericin B (2 mg/liter) (medium M2). A comparative study of the isolation of Campylobacter spp. from stool specimens was carried out with medium M1; medium M2; a selective blood-free medium consisting (per liter) of charcoal (4 g), ferrous sulfate (0.25 g), sodium pyruvate (0.25 g), casein hydrolysate (3 g), sodium deoxycholate (1 g), nutrient broth no. 2 (25 g), agar (12 g), and cefoperazone (32 mg) (medium M3); and Preston medium containing (per liter) trimethoprim (10 mg), rifampin (10 mg), polymyxin B (5,000 IU), and cycloheximide (100 mg) (medium M4). We also included a filtration system in which membrane filters were applied directly to the surface of the nonselective blood-free medium distributed in small petri dishes. A total of 5,276 stool specimens were tested: 2,788 stool specimens were tested on M1 and M3 in study 1; 2,488 stool specimens were inoculated on the four selective media in study 2, and the last 986 specimens of the 2,488 were tested in parallel with the filtration system. In study 2, 128 Campylobacter strains were isolated from 126 different patients; 85.0, 88.3, 82.5, and 66.6% of these strains were isolated on M1, M2, M3, and M4, respectively. No contaminating fecal flora was found on 65.4, 70.7, 62.4, and 40.3% of the M1, M2, M3, and M4 plates, respectively. Furthermore, C. coli was found to be more susceptible to antibiotics present in the selective media, particularly colistin and polymyxin B, than was C. jejuni. We therefore recommend M2 for the isolation of Campylobacter spp. Finally, the filtration method was found to be easy and cheap; although the sensitivity was low, this method allowed the isolation of new Campylobacter spp. which seem to be associated with diarrhea.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3771769      PMCID: PMC269038          DOI: 10.1128/jcm.24.5.840-843.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Campylobacter enteritis: a "new" disease.

Authors:  M B Skirrow
Journal:  Br Med J       Date:  1977-07-02

Review 2.  Campylobacter enteritis.

Authors:  J P Butzler; M B Skirrow
Journal:  Clin Gastroenterol       Date:  1979-09

3.  Related vibrio in stools.

Authors:  J P Butzler; P Dekeyser; M Detrain; F Dehaen
Journal:  J Pediatr       Date:  1973-03       Impact factor: 4.406

4.  A selective medium for isolating Campylobacter jejuni/coli.

Authors:  F J Bolton; L Robertson
Journal:  J Clin Pathol       Date:  1982-04       Impact factor: 3.411

5.  Differentiation of enteropathogenic Campylobacter.

Authors:  M B Skirrow; J Benjamin
Journal:  J Clin Pathol       Date:  1980-11       Impact factor: 3.411

6.  Blood-free selective medium for isolation of Campylobacter jejuni from feces.

Authors:  F J Bolton; D N Hutchinson; D Coates
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

7.  Campylobacter enteritis: clinical and epidemiologic features.

Authors:  M J Blaser; I D Berkowitz; F M LaForce; J Cravens; L B Reller; W L Wang
Journal:  Ann Intern Med       Date:  1979-08       Impact factor: 25.391

8.  Evaluation of a blood-free, charcoal-based, selective medium for the isolation of Campylobacter organisms from feces.

Authors:  M A Karmali; A E Simor; M Roscoe; P C Fleming; S S Smith; J Lane
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

9.  A new selective medium for the isolation of Campylobacter jejuni from human faeces.

Authors:  H Goossens; M De Boeck; J P Butzler
Journal:  Eur J Clin Microbiol       Date:  1983-08       Impact factor: 3.267

10.  Bacteriostatic and bactericidal activities of 24 antimicrobial agents against Campylobacter fetus subsp. jejuni.

Authors:  R Vanhoof; B Gordts; R Dierickx; H Coignau; J P Butzler
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

View more
  22 in total

1.  Isolation of Campylobacter spp. from stool specimens with a semisolid medium.

Authors:  H Goossens; J P Butzler
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

2.  Human disease associated with "Campylobacter upsaliensis" (catalase-negative or weakly positive Campylobacter species) in the United States.

Authors:  C M Patton; N Shaffer; P Edmonds; T J Barrett; M A Lambert; C Baker; D M Perlman; D J Brenner
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

3.  Prevalence of Campylobacter, Arcobacter, Helicobacter, and Sutterella spp. in human fecal samples as estimated by a reevaluation of isolation methods for Campylobacters.

Authors:  J Engberg; S L On; C S Harrington; P Gerner-Smidt
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

4.  Improvement of modified charcoal-cefoperazone-deoxycholate agar by supplementation with a high concentration of polymyxin B for detection of Campylobacter jejuni and C. coli in chicken carcass rinses.

Authors:  Jung-Whan Chon; Ji-Yeon Hyeon; Jin-Hyuk Yim; Jong-Hyun Kim; Kwang-Young Song; Kun-Ho Seo
Journal:  Appl Environ Microbiol       Date:  2011-12-30       Impact factor: 4.792

5.  Isolation of Campylobacter upsaliensis from stool specimens.

Authors:  H Goossens; J P Butzler
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

6.  Characterization and description of "Campylobacter upsaliensis" isolated from human feces.

Authors:  H Goossens; B Pot; L Vlaes; C Van den Borre; R Van den Abbeele; C Van Naelten; J Levy; H Cogniau; P Marbehant; J Verhoef
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

7.  Contribution of the multidrug efflux transporter CmeABC to antibiotic resistance in different Campylobacter species.

Authors:  Baoqing Guo; Jun Lin; Donald L Reynolds; Qijing Zhang
Journal:  Foodborne Pathog Dis       Date:  2010-01       Impact factor: 3.171

8.  Development and application of a real-time polymerase chain reaction method for Campylobacter jejuni detection.

Authors:  Mao-Jun Zhang; Bo Qiao; Xue-Bin Xu; Jian-Zhong Zhang
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

9.  Occurrence of plasmids in "Campylobacter upsaliensis" (catalase negative or weak group) from geographically diverse patients with gastroenteritis or bacteraemia.

Authors:  R J Owen; J Hernandez
Journal:  Eur J Epidemiol       Date:  1990-06       Impact factor: 8.082

10.  Direct isolation of atypical thermophilic Campylobacter species from human feces on selective agar medium.

Authors:  S L Walmsley; M A Karmali
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.